Clinical Trials Browser

Phase 1/2 × Colorectal Neoplasms × dabrafenib × Clear all

NCT01750918 2021-10-29

BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)

Phase 1/2 Completed

166 enrolled 46 charts

Gastrointestinal

Neoplasms, Colorectal Neoplasms